Delhi High Court · 2024-07-12 · 2024 SCC OnLine Del 4421
Public-health approvals are disclosable; proprietary formulations are not.
| Court | Delhi High Court |
|---|---|
| Decided | 2024-07-12 |
| Citation | 2024 SCC OnLine Del 4421 |
| Bench | S, a, n, j, e, e, v, , N, a, r, u, l, a, , J |
| Petitioner | Dr. K. Ramachandran |
| Respondent | Ministry of Ayush |
| RTI Act sections | §4(1)(b), §8(1)(d) |
| Outcome | Applicant allowed |
Ayush drug-licence approval data is public health information under §4(1)(b); commercial formulations remain §8(1)(d).
Drug licences granted for Ayurveda, Unani, Siddha and Homoeopathy formulations concern public health and are §4(1)(b) information. The commercial formulation itself is protected under §8(1)(d) as it is trade-secret property. Labelling, indications approved, and licence conditions are disclosable.
Ayush, drug approvals, section 4(1)(b), section 8(1)(d), public health
These rulings have the closest editorial ratio to this case — computed by tf-idf cosine similarity over ratio, keywords and Act sections. Useful starting points if you are researching the same point of law.
Editorial summary, not a certified report. The ratio here is an editorial compression. Before citing this ruling in a PIO order, FAA speaking order, or any appellate filing, verify against the full reported decision. RTI Wiki is not a legal service.
Editorial summary · last reviewed 21 April 2026.